U2AF2 and cancer: Collectively, U2AF2 cancer-associated mutations falling within the two RRMs impact the equilibrium between the “closed” (unbound) and “open” (RNA binding-competent) conformations, alter binding of the protein to the PPT, and dysregulate pre-mRNA splicing, similarly to U2AF1 mutations.